A ginger-derived compound showed activity against drug-resistant bacteria and increased the activity of four antibiotics in ...

What initially looked like a bruise developed into a serious medical ordeal requiring surgery and weeks in the hospital.

Acurx Pharma announces scientific partnership with Leiden University Medical Center to advance development of Acurx's DNA polymerase IIIC inhibitor antibiotics: Staten Island, New ...

STATEN ISLAND, N.Y., Aug. 14, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics ...

Donna Adelson is appealing her conviction for plotting the murder-for-hire of her former son-in-law, FSU professor Dan Markel ...

Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Acurx Pharma’s DNA Polymerase IIIC inhibitor antibiotics receives Japanese & Mexico patents: Staten Island, New York Friday, August 14, 2026, 12:00 Hrs [IST] Acurx Pharmaceutica ...

The Cleveland Browns are still looking for help on the edge and brought in Tyus Bowser as he makes a comeback attempt. The post Browns Work Out Controversial Edge Rusher in Comeback Attempt appeared ...

Every 15 minutes, someone in the U.S. dies from a drug-resistant superbug. A few decades from now, antibiotic-resistant bacterial infections threaten to become the leading cause of death worldwide, ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company ...